Table 2.
Demographic and clinical characteristics | Total sample | Sample characteristics by each randomization factora |
|||||||
---|---|---|---|---|---|---|---|---|---|
Relaxation |
Worry practice |
Cognitive restructuring |
Telecoaching |
||||||
Yes | No | Yes | No | Yes | No | Yes | No | ||
Sample size, No. | 196 | 98 | 98 | 98 | 98 | 98 | 98 | 97 | 99 |
Demographics | |||||||||
Mean age at screening (SD), y | 54.7 (9.8) | 54.6 (9.3) | 54.8 (10.2) | 55.0 (9.4) | 54.4 (10.2) | 53.7 (10.0) | 55.6 (9.5) | 54.1 (10.1) | 55.3 (9.4) |
Range | 26.0-76.0 | 30.0-74.0 | 26.0-76.0 | 30.0-76.0 | 26.0-74.0 | 26.0-74.0 | 30.0-76.0 | 26.0-76.0 | 33.0-76.0 |
Race, No. (%) | |||||||||
Non-Hispanic White | 174 (88.8) | 90 (91.8) | 84 (85.7) | 87 (87.9) | 87 (89.7) | 84 (85.7) | 90 (91.8) | 89 (91.8) | 85 (85.9) |
Hispanic White | 9 (4.6) | 4 (4.1) | 5 (5.1) | 6 (6.1) | 3 (3.1) | 6 (6.1) | 3 (3.1) | 4 (4.1) | 5 (5.1) |
Non-Hispanic African American | 6 (3.1) | 1 (1.0) | 5 (5.1) | 3 (3.0) | 3 (3.1) | 2 (2.0) | 4 (4.1) | 3 (3.1) | 3 (3.0) |
Non-Hispanic Asian | 4 (2.0) | 2 (2.0) | 2 (2.0) | 1 (1.0) | 3 (3.1) | 4 (4.1) | 0 (0.0) | 1 (1.0) | 3 (3.0) |
Other | 1 (0.5) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) |
Missing | 2 (1.0) | 0 (0.0) | 2 (2.0) | 1 (1.0) | 1 (1.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) | 2 (2.0) |
Latinx, No. (%) | |||||||||
No | 184 (93.9) | 93 (94.9) | 91 (92.9) | 91 (91.9) | 93 (95.9) | 90 (91.8) | 94 (95.9) | 93 (95.9) | 91 (91.9) |
Yes | 11 (5.6) | 4 (4.1) | 7 (7.1) | 7 (7.1) | 4 (4.1) | 7 (7.1) | 4 (4.1) | 4 (4.1) | 7 (7.1) |
Missing | 1 (0.5) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) |
Education, No. (%) | |||||||||
Some high school | 1 (0.5) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) |
High school graduate | 7 (3.6) | 4 (4.1) | 3 (3.1) | 4 (4.0) | 3 (3.1) | 2 (2.0) | 5 (5.1) | 2 (2.1) | 5 (5.1) |
Vocational or technical school | 15 (7.7) | 4 (4.1) | 11 (11.2) | 6 (6.1) | 9 (9.3) | 3 (3.1) | 12 (12.2) | 6 (6.2) | 9 (9.1) |
Some college/associate’s | 40 (20.4) | 15 (15.3) | 25 (25.5) | 21 (21.2) | 19 (19.6) | 23 (23.5) | 17 (17.4) | 25 (25.8) | 15 (15.2) |
College graduate | 71 (36.2) | 35 (35.7) | 36 (36.7) | 34 (34.3) | 37 (38.1) | 41 (41.8) | 30 (30.6) | 26 (26.8) | 45 (45.5) |
Graduate or professional school | 53 (27.0) | 33 (33.7) | 20 (20.4) | 27 (27.3) | 26 (26.8) | 24 (24.5) | 29 (29.6) | 33 (34.0) | 20 (20.2) |
Other | 2 (1.0) | 2 (2.0) | 0 (0.0) | 2 (2.0) | 0 (0.0) | 0 (0.0) | 2 (2.0) | 1 (1.0) | 1 (1.0) |
Missing | 7 (3.6) | 4 (4.1) | 3 (3.1) | 4 (4.0) | 3 (3.1) | 4 (4.1) | 3 (3.1) | 3 (3.1) | 4 (4.0) |
Marital status, No. (%) | |||||||||
Single | 19 (9.7) | 13 (13.3) | 6 (6.1) | 9 (9.1) | 10 (10.3) | 8 (8.2) | 11 (11.2) | 15 (15.5) | 4 (4.0) |
Married/domestic partnership | 153 (78.1) | 73 (74.5) | 80 (81.6) | 76 (76.8) | 77 (79.4) | 77 (78.6) | 76 (77.6) | 73 (75.3) | 80 (80.8) |
Divorced | 17 (8.7) | 9 (9.2) | 8 (8.2) | 10 (10.1) | 7 (7.2) | 6 (6.1) | 11 (11.2) | 7 (7.2) | 10 (10.1) |
Separated | 2 (1.0) | 1 (1.0) | 1 (1.0) | 1 (1.0) | 1 (1.0) | 2 (2.0) | 0 (0.0) | 0 (0.0) | 2 (2.0) |
Widowed | 5 (2.6) | 2 (2.0) | 3 (3.1) | 3 (3.0) | 2 (2.1) | 5 (5.1) | 0 (0.0) | 2 (2.1) | 3 (3.0) |
Employment status, No. (%) | |||||||||
Employed ≥32 h/wk | 123 (62.8) | 61 (62.2) | 62 (63.3) | 58 (58.6) | 65 (67.0) | 60 (61.2) | 63 (64.3) | 68 (70.1) | 55 (55.6) |
Unemployed | 6 (3.1) | 1 (1.0) | 5 (5.1) | 3 (3.0) | 3 (3.1) | 3 (3.1) | 3 (3.1) | 3 (3.1) | 3 (3.0) |
Homemaker | 18 (9.2) | 11 (11.2) | 7 (7.1) | 9 (9.1) | 9 (9.3) | 11 (11.2) | 7 (7.1) | 5 (5.2) | 13 (13.1) |
Retired | 34 (17.4) | 18 (18.4) | 16 (16.3) | 18 (18.2) | 16 (16.5) | 18 (18.4) | 16 (16.3) | 15 (15.5) | 19 (19.2) |
Disabled/medical leave | 5 (2.6) | 3 (3.1) | 2 (2.0) | 4 (4.0) | 1 (1.0) | 1 (1.0) | 4 (4.1) | 0 (0.0) | 5 (5.1) |
Student | 3 (1.5) | 1 (1.0) | 2 (2.0) | 2 (2.0) | 1 (1.0) | 1 (1.0) | 2 (2.0) | 3 (3.1) | 0 (0.0) |
Other | 2 (1.0) | 1 (1.0) | 1 (1.0) | 2 (2.0) | 0 (0.0) | 1 (1.0) | 1 (1.0) | 2 (2.1) | 0 (0.0) |
Missing | 5 (2.6) | 2 (2.0) | 3 (3.1) | 3 (3.0) | 2 (2.1) | 3 (3.1) | 2 (2.0) | 1 (1.0) | 4 (4.0) |
Diagnostic history | |||||||||
Stage at diagnosis, No. (%) | |||||||||
Stage 0 | 5 (2.6) | 1 (1.0) | 4 (4.1) | 5 (5.1) | 0 (0.0) | 2 (2.0) | 3 (3.1) | 2 (2.1) | 3 (3.0) |
Stage I | 87 (44.4) | 48 (49.0) | 39 (39.8) | 40 (40.4) | 47 (48.5) | 42 (42.9) | 45 (45.9) | 47 (48.5) | 40 (40.4) |
Stage II | 78 (39.8) | 35 (35.7) | 43 (43.9) | 42 (42.4) | 36 (37.1) | 42 (42.9) | 36 (36.7) | 39 (40.2) | 39 (39.4) |
Stage III | 26 (13.3) | 14 (14.3) | 12 (12.2) | 12 (12.1) | 14 (14.4) | 12 (12.2) | 14 (14.3) | 9 (9.3) | 17 (17.2) |
Mean age at diagnosis (SD), y | 51.8 (9.4) | 51.7 (8.8) | 51.8 (9.9) | 52.1 (8.9) | 51.4 (9.8) | 50.5 (9.3) | 53.0 (9.2) | 51.0 (9.8) | 52.5 (8.9) |
Range | 24.8-73.6 | 28.6-68.6 | 24.8-73.6 | 28.6-73.6 | 24.8-68.9 | 24.8-68.9 | 28.6-73.6 | 24.8-73.6 | 30.6-71.3 |
Mean time since diagnosis (SD), y | 3.5 (3.0) | 3.4 (3.1) | 3.6 (2.9) | 3.4 (2.8) | 3.5 (3.2) | 3.7 (3.4) | 3.2 (2.5) | 3.6 (3.2) | 3.3 (2.7) |
Range | 0.2-19.1 | 0.3-19.1 | 0.2-16.9 | 0.2-15.2 | 0.4-19.1 | 0.2-19.1 | 0.4-15.2 | 0.4-19.1 | 0.2-15.2 |
Treatment history | |||||||||
Mean time since treatment (SD), y | 2.8 (2.5) | 2.6 (2.4) | 3.0 (2.6) | 3.0 (2.8) | 2.6 (2.0) | 2.9 (2.4) | 2.7 (2.6) | 2.7 (2.1) | 2.9 (2.8) |
Range | 0.1-15.0 | 0.1-15.0 | 0.1-13.3 | 0.1-15.0 | 0.1-12.0 | 0.1-13.3 | 0.1-15.0 | 0.1-13.3 | 0.1-15.0 |
Treatment received, No. (%) | |||||||||
Surgery only | 21 (10.7) | 8 (8.2) | 13 (13.3) | 11 (11.1) | 10 (10.3) | 13 (13.3) | 8 (8.2) | 8 (8.3) | 13 (13.1) |
Chemotherapy only | 1 (0.5) | 0 (0.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) |
Surgery + chemotherapy | 37 (18.9) | 20 (20.4) | 17 (17.4) | 21 (21.2) | 16 (16.5) | 18 (18.4) | 19 (19.4) | 18 (18.6) | 19 (19.2) |
Surgery + RT | 37 (18.9) | 20 (20.4) | 17 (17.4) | 19 (19.2) | 18 (18.6) | 14 (14.3) | 23 (23.5) | 21 (21.7) | 16 (16.2) |
Surgery + chemotherapy + RT | 99 (50.5) | 50 (51.0) | 49 (50.0) | 46 (46.5) | 53 (54.6) | 53 (54.1) | 46 (46.9) | 49 (50.5) | 50 (50.5) |
Missing | 1 (0.5) | 0 (0.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) |
Targeted therapy, No. (%) | |||||||||
None | 148 (75.5) | 77 (78.6) | 71 (72.5) | 76 (76.8) | 72 (74.2) | 77 (78.6) | 71 (72.5) | 76 (78.4) | 72 (72.7) |
Received | 43 (21.9) | 17 (17.4) | 26 (26.5) | 22 (22.2) | 21 (21.7) | 18 (18.4) | 25 (25.5) | 19 (19.6) | 24 (24.2) |
Missing | 5 (2.6) | 4 (4.1) | 1 (1.0) | 1 (1.0) | 4 (4.1) | 3 (3.1) | 2 (2.0) | 2 (2.1) | 3 (3.0) |
Hormonal therapy, No. (%) | |||||||||
No | 38 (19.4) | 14 (14.3) | 24 (24.5) | 21 (21.2) | 17 (17.5) | 22 (22.5) | 16 (16.3) | 17 (17.5) | 21 (21.2) |
Current | 137 (69.9) | 73 (74.5) | 64 (65.3) | 66 (66.7) | 71 (73.2) | 70 (71.4) | 67 (68.4) | 65 (67.0) | 72 (72.7) |
Past | 20 (10.2) | 10 (10.2) | 10 (10.2) | 12 (12.1) | 8 (8.3) | 6 (6.1) | 14 (14.3) | 14 (14.4) | 6 (6.1) |
Missing | 1 (0.5) | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) |
Participants were randomly assigned independently to each factor. Data were provided for full sample and separately by factor to demonstrate balanced randomization regarding demographics, clinical characteristics, and FoR at baseline. Sample size for each factor totaled 196; therefore, sample size summed across rows exceed 196. RT = radiation therapy.